Study Title: Treatment of Early Aggressive Rheumatoid Arthritis
Category: Arthritis
Currently accepting participants?
Not at this time.
Principal Investigator: Jeffrey Carlin MD
Study Coordinator: Jill Zeller RN
Phone: 206-223-6835
Email: jill.zeller@vmmc.org
What is the Treatment of Early Aggressive Rheumatoid Arthritis study?
Who can participate?
Study Summary:
Detailed Study Description:
Study Design: Blinded
Phase of Study: Phase IV
Study Type: Interventional
Condition or Study Focus: Rheumatoid Arthritis
Intervention Type: Drug
Intervention Name: Combinations of FDA-approved: methotrexate, hydroxychoroquine, sulfasalazine and etanercept.
Gender: Male and Female
Age group: Interventional
Sponsor: University of Alabama at Birmingham
Studies currently accepting study participants:
Studies currently not accepting study participants: